Clinical trial
Umbilical Cord Glucose: A Novel Screening Method for Congenital Hyperinsulinism to Prevent Brain Damage
NCT07795047 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Umbilical Cord Glucose: A Novel Screening Method for Congenital Hyperinsulinism to Prevent Brain Damage
- Lead sponsor
- Odense University Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- August 31, 2028
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
congenital hyperinsulinism (chi)